Inside The Theranos Trial — With Erin Griffith of The New York Times
Big Technology Podcast
00:00
Examining Theranos: A Tech Company or an Outlier?
This chapter discusses the implications of the Theranos trial on the technology sector, debating its classification as a tech or medical device company. It examines Silicon Valley norms and venture capitalists' reactions, framing Theranos' actions as either typical startup behavior or an isolated incident.
Play episode from 24:18
Transcript
